Mind your "Q"s: QPharma acquires Qforma
Combination expands breadth of commercialization and compliance services
Two New Jersey-based companies, both with expertise in life sciences commercial services, will now be known only as QPharma. Qforma, until now owned by a private investment firm, BelHealth Investment Partners, has developed analytics technology for “understanding and penetration” of professional relationship networks among healthcare providers and their affiliations, as well as a launch planning tool, iLaunch.
For 21 years, QPharma has provided a range of IT-based services, including systems validation, sample distribution management, state and federal transparency reporting and salesforce training. More recently, it has moved into key opinion-leader (KOL) identification, influence mapping and analytics.
“The purchase of Qforma is a natural progression of the incremental growth strategy that has served QPharma well in the past two decades,” said QPharma president and CEO, Patrick Den Boer, in a statement. “The outstanding technology platform and solution base they have built is a perfect complement to QPharma’s suite of business intelligence tools.”
Purchase price was not disclosed. QPharma says that its national headcount will get a 10% bump-up, but didn't release a total employment figure.
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
January 14th 2025The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
